Literature DB >> 2661612

The effects of methylphenidate on learning in children with ADDH: the stimulus equivalence paradigm.

Stuart A Vyse1, Mark D Rapport.   

Abstract

Investigated the effect of methylphenidate (MPH) on the ability of children with Attention Deficit Disorder with Hyperactivity (ADDH) to learn both trained and untrained complex visual relationships and compared these findings to their school performance under identical dosage parameters. 26 children between the ages of 6 and 12 years with ADDH participated in a double-blind, placebo control, within-subjects design in which each child received four doses of MPH (5, 10, 15, 20 mg) and a placebo in a counterbalanced sequence. MPH enhanced children's learning of both taught and untaught visual relationships, and most changes were similar to, albeit less dramatic than, those obtained for the children's attention and academic performance in school. Results of group and single-subject analyses are presented and discussed with relevance to psychopharmacological research and understanding the complex relationship between learning and psychostimulants used in treating children with ADDH.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661612     DOI: 10.1037/0022-006X.57.3.425

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  6 in total

1.  Mechanisms and performance measures in mastery-based incremental repeated acquisition: behavioral and pharmacological analyses.

Authors:  Jordan M Bailey; Joshua E Johnson; M Christopher Newland
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

2.  Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance.

Authors:  M D Rapport; S O Quinn; G J DuPaul; E P Quinn; K L Kelly
Journal:  J Abnorm Child Psychol       Date:  1989-12

Review 3.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

4.  Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1).

Authors:  Tatjana Meyer; Nikolaus Jahn; Stefanie Lindner; Linda Röhner; Anna Dolnik; Daniela Weber; Annika Scheffold; Simon Köpff; Peter Paschka; Verena I Gaidzik; Dirk Heckl; Sebastian Wiese; Benjamin L Ebert; Hartmut Döhner; Lars Bullinger; Konstanze Döhner; Jan Krönke
Journal:  Leukemia       Date:  2019-10-01       Impact factor: 11.528

Review 5.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

Review 6.  How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis.

Authors:  Vibhore Prasad; Ellen Brogan; Caroline Mulvaney; Matthew Grainge; Wendy Stanton; Kapil Sayal
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-11-21       Impact factor: 4.785

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.